Ayala Pharmaceuticals Inc (ADXS)
0.437
-0.12
(-21.96%)
USD |
OTCM |
May 10, 15:29
Ayala Pharmaceuticals Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -8.168M |
| September 30, 2022 | -9.335M |
| June 30, 2022 | -7.023M |
| March 31, 2022 | -9.984M |
| December 31, 2021 | -7.792M |
| September 30, 2021 | -9.367M |
| June 30, 2021 | -11.55M |
| March 31, 2021 | -9.649M |
| Date | Value |
|---|---|
| December 31, 2020 | -6.973M |
| September 30, 2020 | -8.862M |
| June 30, 2020 | -5.315M |
| March 31, 2020 | -6.391M |
| December 31, 2019 | -3.694M |
| September 30, 2019 | -5.152M |
| June 30, 2019 | -2.542M |
| March 31, 2019 | -3.562M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.55M
Minimum
Jun 2021
-2.542M
Maximum
Jun 2019
-7.453M
Average
-7.792M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -1.30K% |